ARTICLE | Company News
Debiopharm sales and marketing update
May 19, 2008 7:00 AM UTC
An undisclosed European pharmaceutical company received a license to market Debiopharm's Salvacyl/ Moapar triptorelin to treat severe sexual deviations in adult men. The gonadotropin-releasing hormon...